Capecitabine is a prodrug-type DNA synthesis inhibitor. It affects ERS/ROS/mitochondrial and ferroptosis signaling pathways. By metabolizing into 5-FU to disrupt DNA metabolism and induce oxidative stress, it inhibits tumor cell proliferation and promotes apoptosis.
Capecitabine IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Capecitabine Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Capecitabine Mechanism of Action: Thymidylate Synthase Inhibition in Breast Cancer Cell Research
- Capecitabine Clinical Trials
- Capecitabine Working Concentration | Cell Culture | Treatment
- Capecitabine Solubility in DMSO
- Capecitabine Stock Solution
- Capecitabine Storage
- Capecitabine Stability
- Capecitabine Combination Database
- Capecitabine Molecular Weight
- Capecitabine SMILES
- Capecitabine CAS Number
- Capecitabine Chemical Structure (2D and 3D)
- Capecitabine Sigma (PHR1405)? Try a better option.
- Capecitabine Cayman (10487)? Try a better option.
- Capecitabine APExBIO (A8647)? Try a better option.
- Capecitabine MedChemExpress (HY-B0016)? Try a better option.
- Capecitabine SDS｜MSDS